z-logo
open-access-imgOpen Access
SUN-336 Autocrine / Paracrine Growth Hormone (GH) Drives Multimodal Therapy Resistance in Growth Hormone Receptor (GHR)-expressing Human Cancers
Author(s) -
Reetobrata Basu,
Emily F. Davis-Marcisak,
Diego Ibarra,
Colin P. S. Kruse,
Kevin Funk,
Silvana Durán Ortiz,
Alison Brittain,
Yanrong Qian,
John J. Kopchick
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sun-336
Subject(s) - growth hormone receptor , autocrine signalling , paracrine signalling , cancer research , biology , medicine , cancer , endocrinology , receptor , hormone , growth hormone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom